Creatine after 60: stronger muscles or another longevity promise?

Why creatine belongs in the aging conversation

The most meaningful question is not whether creatine makes an aging biomarker look younger. It is whether people can get up from a chair, recover from activity, carry their shopping and maintain strength. Muscle capacity is central to those everyday abilities.

Creatine helps replenish phosphocreatine, an energy reserve used during brief, intense muscular efforts. That mechanism makes it a plausible training aid. But a plausible mechanism does not settle whether a supplement offers useful additional benefit to an older person already exercising.

What the newest synthesis found

A 2026 systematic review pooled 11 randomized controlled trials comparing creatine plus resistance training with resistance training alone or placebo plus training in adults aged 60 or older.

The pooled standardized effect on strength was small but positive (Hedges' g 0.31, 95% CI 0.18–0.45), with moderate certainty. For muscle mass (g 0.35, 95% CI −0.09 to 0.78) and physical function (g 0.47, 95% CI −0.08 to 1.03), confidence intervals included no effect and certainty was lower.

This distinction matters: a measurable increase on a strength test does not automatically mean fewer falls, more independence or fewer hospitalizations. Those outcomes require their own evidence.

Source [1]

Why different meta-analyses can disagree

A 2025 analysis of eight randomized trials involving 482 participants reported small improvements in lower-body strength and lean tissue mass with creatine plus resistance training. The results varied across outcomes and durations.

The 2026 synthesis included more trials and used a model accounting for multiple related effect estimates from individual studies. Differences in included populations, statistical methods and endpoint selection can change conclusions, particularly when the total evidence base remains modest.

It would be misleading to take whichever pooled result is most favorable and announce that the science is settled. The more stable message is that strength shows the clearest additive signal, while mass and functional improvements are less consistent.

Source [2]Source [1]

Where the evidence does—and does not—apply

Most trials concern relatively healthy older volunteers taking creatine during supervised or structured resistance training. They do not show that creatine alone can replace exercise. They also do not establish the same effects in people with severe frailty, advanced kidney disease or complex medical conditions.

Research on cognition, bone health and biological aging is often mentioned in popular discussions. These are separate outcome questions. A strength meta-analysis cannot be used as proof of brain rejuvenation, fracture prevention or lifespan extension.

What about safety?

Creatine is widely studied, but short- to medium-term trial experience is not a lifetime safety guarantee. Kidney disease, medication interactions, fluid-balance concerns and interpretation of creatinine blood tests are reasons to discuss supplementation with a clinician rather than treating it as universally harmless.

Even an average favorable adverse-event profile in a trial may miss rare harms or exclude people most vulnerable to them. The evidence is strongest for the populations and durations actually studied.

The AgeBeacon take

Creatine is a useful example of a supplement with a testable, fairly modest human effect: it may help older adults get slightly stronger when paired with resistance training. That is more credible than a sweeping 'anti-aging' claim, and it may still be valuable to someone who cares about physical capacity.

The unanswered question is whether the extra strength translates into reliably better daily function or fewer important clinical events. Until those results are clearer, creatine should not be described as proven longevity medicine.